Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
House of Representatives, Congress."
House Hearing, 115th Congress
- EXAMINING FDA'S GENERIC DRUG AND BIOSIMILAR USER FEE PROGRAMS. Government. U.S. Government Publishing Office https://www.govinfo.gov/app/details/CHRG-115hhrg25222.
APA
House of Representatives, Congress. (2017, March 2). Serial No. 115-10 - EXAMINING FDA'S GENERIC DRUG AND BIOSIMILAR USER FEE PROGRAMS. [Government]. U.S. Government Publishing Office. https://www.govinfo.gov/app/details/CHRG-115hhrg25222
MLA
House of Representatives, Congress. Serial No. 115-10 - EXAMINING FDA'S GENERIC DRUG AND BIOSIMILAR USER FEE PROGRAMS. U.S. Government Publishing Office, (2 Mar 2017), https://www.govinfo.gov/app/details/CHRG-115hhrg25222
Bluebook
House of Representatives, Congress, EXAMINING FDA'S GENERIC DRUG AND BIOSIMILAR USER FEE PROGRAMS, GovInfo, (March 2, 2017), https://www.govinfo.gov/app/details/CHRG-115hhrg25222
